Alkermes plc.(ALKS)— Stock Profile, AI Score & Financials
Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
Alkermes plc. (ALKS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ALKS at 45.2/100 on a 32-signal composite quality model, placing it at rank #1,874 of 2,961 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Alkermes plc. reports quarterly revenue of $496.0M, net income of $501.0K, an operating margin of 3.7%. Top institutional holders of ALKS by reported 13-F value include BlackRock, BAKER BROS. ADVISORS, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. ALKS trades on the Nasdaq exchange and files with the SEC under CIK 1520262. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ALKS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Alkermes plc. directly from SEC EDGAR.
AI Quality Score
45.2/100
AI Rank
#1,874
Revenue
$496.0M
Net Income
$501.0K
Free Cash Flow
$137.0M
Operating Margin
3.7%
ALKS key financials by period
Alkermes plc. reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2025
10-K
$1.5B
$241.7M
17.2%
FY 2024
10-K
$1.6B
$367.1M
27.0%
FY 2023
10-K
$1.7B
$355.8M
24.9%
FY 2022
10-K
$1.1B
$-158.3M
-0.5%
FY 2021
10-K
$1.2B
$-48.2M
8.3%
FY 2020
10-K
$1.0B
$-110.9M
-10.8%
Institutions holding ALKS
Institutional investors reporting a position in Alkermes plc. on SEC Form 13F.
